Global Derivatives ADV Up 12% Year-over-Year; U.S. Equity Options ADV
Up 17%
NYSE Liffe U.S. Crosses One Million Contracts in Total Exchange Open
Interest
European Cash ADV Up 9%; U.S. Cash ADV Down 11%
NEW YORK--(BUSINESS WIRE)--Jan. 10, 2012--
NYSE Euronext (NYX) today announced trading volumes for its global
derivatives and cash equities exchanges for December 20111.
Global derivatives average daily volume (“ADV”) of 7.5 million contracts
in December 2011 increased 11.8% versus the prior year with U.S. equity
options increasing 17.1%. Cash equities ADV in December 2011 were mixed,
with European cash trading ADV increasing 9.0% and U.S. cash trading ADV
decreasing 10.6% from December 2010 levels.
Highlights
-
NYSE Euronext global derivatives ADV in December 2011 of 7.5 million
contracts increased 11.8% compared to December 2010, but decreased
10.1% from November 2011 levels.
-
NYSE Euronext European derivatives products ADV in December 2011 of
3.4 million contracts increased 4.2% compared to December 2010, but
decreased 13.4% from November 2011 levels. Excluding Bclear, NYSE
Liffe's trade administration and clearing service for OTC products,
European derivatives products ADV decreased 8.3% compared to December
2010 and decreased 29.5% from November 2011.
-
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9
million contracts in December 2011 increased 17.1% compared to
December 2010 levels, but decreased 7.3% from November 2011. NYSE
Euronext’s U.S. options exchanges accounted for 27.7% of total U.S.
consolidated equity options trading in December 2011, up from 23.1% in
December 2010, but down from a record 28.1% in November 2011.
-
NYSE Liffe U.S. ADV of approximately 89,600 contracts increased from
13,000 contracts in December 2010 and increased from 88,500 contracts
in November 2011.
-
NYSE Liffe U.S. reached one million lots in total Exchange Open
Interest in December 2011, less than one year after introducing its
suite of interest rate futures contracts, underscoring the liquidity
across asset classes and continued high levels of customer
participation. Open interest market share in Eurodollar futures
represented 10% of open interest traded on our nearest competitor.
-
NYSE Euronext European cash products ADV of 1.3 million transactions
in December 2011 increased 9.0% compared to December 2010, but
decreased 19.9% from November 2011 levels.
-
NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex)
handled ADV of 1.8 billion shares in December 2011 decreased 10.6%
compared to December 2010 and decreased 14.9% compared to November
2011. NYSE Euronext’s Tape A matched market share in December 2011 was
33.4%, down from 35.0% in December 2010 and down from 34.1% in
November 2011.
-
There were a total of 21 trading days in Europe and the U.S. in
December 2011 compared to 23 trading days in Europe and 22 trading
days in the U.S. in December 2010.
-
The preliminary average net revenue per transaction type (as defined
below) for each of the primary trading venues in the fourth quarter of
2011 is included below:
|
|
|
3Q11 Actual
|
|
4Q11 Preliminary
|
|
European Derivatives (ex. Bclear)1
|
|
$0.679
|
|
$0.698
|
|
U.S. Derivatives2
|
|
$0.154
|
|
$0.148
|
|
European Cash3
|
|
$0.635
|
|
$0.579
|
|
U.S. Cash4
|
|
$0.038
|
|
$0.039
|
|
1 Average net revenue per contract, excluding
Bclear.
|
|
2 Average net revenue per contract.
|
|
3 Average net revenue per transaction.
|
|
4 Average net revenue per 100 shares handled.
|
Derivatives Trading
European Derivatives
-
NYSE Euronext European derivatives products ADV in December 2011 was
3.4 million futures and options contracts, an increase of 4.2% from
December 2010, but a decrease of 13.4% from November 2011.
-
The 3.4 million in European derivatives futures and options contracts
ADV in December 2011 consisted of 2.2 million contracts executed
through our full-service LIFFE CONNECT trading platform and 1.2
million contracts, or 36.0%, executed through Bclear, NYSE Liffe's
trade administration and clearing service for OTC products. Excluding
Bclear, European derivatives products ADV decreased 8.3% compared to
December 2010 and decreased 29.5% from November 2011.
-
In the fourth quarter of 2011, European derivatives products ADV of
3.6 million contracts was 3.3% below prior year levels. The 3.6
million in futures and options contracts ADV in the fourth quarter of
2011 consisted of 2.7 million contracts executed through LIFFE CONNECT
trading platform and 0.9 million contracts, or 24.0%, executed through
Bclear. Excluding Bclear, European derivatives products ADV in the
fourth quarter of 2011 decreased 4.5% compared to the prior year
period.
-
For the full-year 2011, European derivatives products ADV of 4.5
million contracts was 5.7% below prior year levels. The 4.5 million in
futures and options contracts ADV For the full-year 2011 consisted of
3.3 million contracts executed through the LIFFE CONNECT trading
platform and 1.1 million contracts, or 25.5%, executed through Bclear.
-
Total fixed income products ADV of 1.4 million contracts in December
2011 decreased 8.2% from December 2010 and decreased 36.7% from
November 2011. In the fourth quarter of 2011, total fixed income
products ADV of 1.8 million contracts was 0.9% below prior year
levels. For the full-year 2011, total fixed income products ADV of 2.3
million contracts was 1.2% below prior year levels.
-
Total equity products (including Bclear) ADV of 2.0 million contracts
in December 2011 increased 14.4% compared to December 2010 and
increased 14.2% from November 2011. The 2.0 million contracts in
equity products ADV consisted of 1.5 million contracts in individual
equity products ADV and 0.5 million contracts in equity index products
ADV. The 1.5 million contracts in individual equity products ADV
consisted of 1.1 million in futures contracts, which represented a
43.8% increase compared to December 2010 and 0.5 million in options
contracts, which represented a 15.2% decrease compared to December
2010. The average net rate per contract for individual equity futures
contracts is significantly lower than other products traded on NYSE
Liffe. In the fourth quarter of 2011, total equity products ADV of 1.7
million contracts was 5.9% below prior year levels. For the full-year
2011, total equity products ADV of 2.1 million contracts was 10.8%
below prior year levels.
-
Total commodities products ADV of 68,000 contracts in December 2011
increased 6.4% compared to December 2010 and was down 0.9% compared to
November 2011. In the fourth quarter of 2011, total commodities
product ADV of 72,000 contracts was 4.2% above prior year levels. For
the full-year 2011, total commodities product ADV of 81,000 contracts
was 24.8% above prior year levels.
U.S. Derivatives
-
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9
million contracts in December 2011 increased 17.1% compared to
December 2010, but decreased 7.3% compared to November 2011. In the
fourth quarter of 2011, U.S. equity options ADV of 4.3 million
contracts was 15.4% above prior year levels. For the full-year 2011,
U.S. equity options ADV of 4.4 million contracts was 20.0% above prior
year levels.
-
Total U.S. consolidated equity options ADV decreased 2.4% to 14.2
million contracts in December 2011 compared to December 2010 and
decreased 5.9% compared to November 2011. In the fourth quarter of
2011, U.S. consolidated equity options ADV of 15.5 million contracts
was 2.4% above prior year levels. For the full-year 2011, U.S.
consolidated equity options ADV of 16.8 million contracts was 17.0%
above prior year levels.
-
NYSE Euronext’s U.S. options exchanges accounted for 27.7% of the
total U.S. consolidated equity options trading in December 2011, up
from 23.1% in December 2010, but down from a record 28.1% in November
2011.
-
NYSE Liffe U.S. ADV of approximately 89,600 contracts increased from
13,000 contracts in December 2010 and increased from 88,500 contracts
in November 2011. In the fourth quarter of 2011, U.S. futures and
futures options ADV was 91,200 contracts compared to 14,900 contracts
in the prior year quarter. For the full-year 2011, U.S. futures and
futures options ADV of 81,200 contracts was 401.3% above prior year
levels, driven by the launch of interest rate futures contracts in
March 2011.
-
NYSE Liffe U.S. reached one million lots in total Exchange Open
Interest in December 2011, less than one year after introducing its
suite of interest rate futures contracts, underscoring the liquidity
across asset classes and continued high levels of customer
participation. Open interest market share in Eurodollar futures
represented 10% of open interest traded on our nearest competitor.
Cash Trading
European Cash
-
NYSE Euronext European cash products ADV of 1.3 million transactions
in December 2011 increased 9.0% compared to December 2010, but
decreased 19.9% compared to November 2011.
-
In the fourth quarter of 2011, European cash products ADV of 1.6
million transactions was 13.2% above prior year levels.
-
For the full-year 2011, European cash products ADV of 1.7 million
transactions was 17.1% above prior year levels.
U.S. Cash
-
NYSE Euronext U.S. cash products handled ADV in December 2011
decreased 10.6% to 1.8 billion shares compared to December 2010 and
decreased 14.9% from November 2011.
-
In the fourth quarter of 2011, U.S. cash products handled ADV was 2.1
billion shares, down 4.5% from prior year levels.
-
For the full-year 2011, U.S. cash products handled ADV was 2.3 billion
shares, down 12.1% from prior year levels.
-
NYSE Euronext’s Tape A matched market share in December 2011 was
33.4%, down from 35.0% in December 2010 and down from 34.1% in
November 2011.
Exchange Traded Funds
-
NYSE Euronext U.S. matched exchange-traded funds ADV (included in
volumes for Tape B and Tape C) of 248 million shares in December 2011
increased 15.7% compared to December 2010, but decreased 22.7%
compared to November 2011.
-
In the fourth quarter of 2011, NYSE Euronext U.S. matched
exchange-traded funds ADV of 323 million shares was 16.9% above prior
year levels.
-
For the full-year 2011, NYSE Euronext U.S. matched exchange-traded
funds ADV of 324 million shares was 2.6% below prior year levels.
Other Metrics
-
On December 22, 2011, BlueNext S.A., a joint venture with Caisse des
Dépôts, reached a settlement with the French tax authorities regarding
its liability arising from a tax audit for the period January
2006 through May 2009. The settlement amount, including penalties, is
€31.8 million. NYSE Euronext will record its 60% share of the joint
venture's settlement amount during the quarter ending December 31,
2011 as a non-recurring charge.
-
The average EUR/USD exchange rate for the fourth quarter of 2011 of
$1.35 represented a decrease of 4.6% from the third quarter of 2011
and a decrease of 0.8% compared to the fourth quarter of 2010.
-
The average GBP/USD exchange rate for the fourth quarter of 2011 of
$1.57 represented a decrease of 2.4% from the third quarter of 2011
and a decrease of 0.5% compared to the third quarter of 2010.
Please click
here for the Monthly Transaction Activity Data Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets
and provider of innovative trading technologies. The company's exchanges
in Europe and the United States trade equities, futures, options,
fixed-income and exchange-traded products. With approximately 8,000
listed issues (excluding European Structured Products), NYSE Euronext's
equities markets – the New York Stock Exchange, NYSE Euronext, NYSE
Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's
equities trading, the most liquidity of any global exchange group. NYSE
Euronext also operates NYSE Liffe, one of the leading European
derivatives businesses and the world's second-largest derivatives
business by value of trading. The company offers comprehensive
commercial technology, connectivity and market data products and
services through NYSE Technologies. NYSE Euronext is in the S&P 500
index, and is the only exchange operator in the Fortune 500. For more
information, please visit: http://www.nyx.com.
Safe Harbour Statement
In connection with the proposed business combination transaction between
NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding
N.V. (“Holding”), a newly formed holding company, filed, and the SEC
declared effective on May 3, 2011, a Registration Statement on Form F-4
with the U.S. Securities and Exchange Commission (“SEC”) that includes
(1) a proxy statement of NYSE Euronext that also constitutes a
prospectus for Holding used in connection with NYSE Euronext special
meeting of stockholders held on July 7, 2011 and (2) an offering
prospectus used in connection with Holding’s offer to acquire Deutsche
Boerse AG shares held by U.S. holders. Holding has also filed an offer
document with the German Federal Financial Supervisory Authority
(Bundesanstalt fuer Finanzdienstleistungsaufsicht) (“BaFin”), which was
approved by the BaFin for publication pursuant to the German Takeover
Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4,
2011.
Investors and security holders are urged to read the definitive proxy
statement/prospectus, the offering prospectus, the offer document, as
amended, and published additional accompanying information in connection
with the exchange offer regarding the proposed business combination
transaction because they contain important information. You may obtain a
free copy of the definitive proxy statement/prospectus, the offering
prospectus and other related documents filed by NYSE Euronext and
Holding with the SEC on the SEC’s website at www.sec.gov.
The definitive proxy statement/prospectus and other documents relating
thereto may also be obtained for free by accessing NYSE Euronext’s
website at www.nyse.com.
The offer document, as amended, and published additional accompanying
information in connection with the exchange offer are available at
Holding’s website at www.global-exchange-operator.com.
This document is neither an offer to purchase nor a solicitation of an
offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext.
The final terms and further provisions regarding the public offer are
disclosed in the offer document that has been approved by the BaFin and
in documents that have been filed with the SEC.
No offering of securities shall be made except by means of a prospectus
meeting the requirements of Section 10 of the U.S. Securities Act of
1933, as amended, and applicable European regulations. The exchange
offer and the exchange offer document as amended, shall not constitute
an issuance, publication or public advertising of an offer pursuant to
laws and regulations of jurisdictions other than those of Germany,
United Kingdom of Great Britain and Northern Ireland and the United
States of America. The relevant final terms of the proposed business
combination transaction will be disclosed in the information documents
reviewed by the competent European market authorities.
Subject to certain exceptions, in particular with respect to qualified
institutional investors (tekikaku kikan toshika) as defined in Article 2
para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law
No. 25 of 1948, as amended), the exchange offer will not be made
directly or indirectly in or into Japan, or by use of the mails or by
any means or instrumentality (including without limitation, facsimile
transmission, telephone and the internet) of interstate or foreign
commerce or any facility of a national securities exchange of Japan.
Accordingly, copies of this announcement or any accompanying documents
may not be, directly or indirectly, mailed or otherwise distributed,
forwarded or transmitted in, into or from Japan.
The shares of Holding have not been, and will not be, registered under
the applicable securities laws of Japan. Accordingly, subject to certain
exceptions, in particular with respect to qualified institutional
investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i)
of the Financial Instruments and Exchange Act of Japan (Law No. 25 of
1948, as amended), the shares of Holding may not be offered or sold
within Japan, or to or for the account or benefit of any person in Japan.
Forward-Looking Statements
This document includes forward-looking statements. By their nature,
forward-looking statements involve risks and uncertainties because they
relate to events and depend on circumstances that may or may not occur
in the future. Forward-looking statements are not guarantees of future
performance and actual results of operations, financial condition and
liquidity, and the development of the industries in which NYSE Euronext
operates may differ materially from those made in or suggested by the
forward-looking statements contained in this document. Any
forward-looking statements speak only as at the date of this document.
Except as required by applicable law, NYSE Euronext does not undertake
any obligation to update or revise publicly any forward-looking
statement, whether as a result of new information, future events or
otherwise.
1 All NYSE Euronext derivatives transactions count buy and
sell orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy and
sell orders together as a single transaction.
|
NYSE Euronext
|
|
|
Monthly Volume Summary
|
|
|
|
|
|
|
|
Average Daily Volume
|
|
Total Volume
|
|
Average Daily Volume
|
|
Total Volume
|
|
|
(Unaudited; contracts in thousands)
|
|
Dec-11
|
|
Dec-10
|
|
% Chg
|
|
Dec-11
|
|
Dec-10
|
|
% Chg
|
|
YTD 2011
|
|
% Chg vs.
YTD 2010
|
|
YTD 2011
|
|
% Chg vs.
YTD 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Trading Days - European Markets
|
|
21
|
|
23
|
|
|
|
|
|
21
|
|
23
|
|
|
|
257
|
|
|
|
257
|
|
|
|
|
Number of Trading Days - U.S. Markets
|
|
21
|
|
22
|
|
|
|
|
|
21
|
|
22
|
|
|
|
252
|
|
|
|
252
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
European Derivatives Products
|
|
3,440
|
|
3,302
|
|
4.2%
|
|
|
|
72,245
|
|
75,957
|
|
-4.9%
|
|
4,469
|
|
-5.7%
|
|
1,148,498
|
|
-6.1%
|
|
|
of which Bclear
|
|
1,240
|
|
903
|
|
37.4%
|
|
|
|
26,046
|
|
20,759
|
|
25.5%
|
|
1,141
|
|
-13.6%
|
|
293,243
|
|
-14.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fixed Income Products
|
|
1,352
|
|
1,473
|
|
-8.2%
|
|
|
|
28,390
|
|
33,877
|
|
-16.2%
|
|
2,250
|
|
-1.2%
|
|
578,255
|
|
-1.6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short Term Interest Rate Products
|
|
1,268
|
|
1,396
|
|
-9.2%
|
|
|
|
26,625
|
|
32,108
|
|
-17.1%
|
|
2,111
|
|
-2.3%
|
|
542,541
|
|
-2.7%
|
|
|
Medium and Long Term Interest Rate Products 1
|
|
84
|
|
77
|
|
9.4%
|
|
|
|
1,766
|
|
1,769
|
|
-0.1%
|
|
139
|
|
18.2%
|
|
35,714
|
|
17.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Equity Products 2
|
|
2,021
|
|
1,766
|
|
14.4%
|
|
|
|
42,432
|
|
40,616
|
|
4.5%
|
|
2,138
|
|
-10.8%
|
|
549,513
|
|
-11.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Individual Equity Products
|
|
1,529
|
|
1,292
|
|
18.3%
|
|
|
|
32,109
|
|
29,725
|
|
8.0%
|
|
1,560
|
|
-13.3%
|
|
401,004
|
|
-13.7%
|
|
|
Futures
|
|
1,056
|
|
734
|
|
43.8%
|
|
|
|
22,168
|
|
16,883
|
|
31.3%
|
|
974
|
|
-13.1%
|
|
250,442
|
|
-13.4%
|
|
|
Options
|
|
473
|
|
558
|
|
-15.2%
|
|
|
|
9,941
|
|
12,841
|
|
-22.6%
|
|
586
|
|
-13.7%
|
|
150,562
|
|
-14.1%
|
|
|
Equity Index Products
|
|
492
|
|
474
|
|
3.8%
|
|
|
|
10,323
|
|
10,892
|
|
-5.2%
|
|
578
|
|
-3.0%
|
|
148,509
|
|
-3.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of which Bclear
|
|
1,240
|
|
903
|
|
37.4%
|
|
|
|
26,046
|
|
20,759
|
|
25.5%
|
|
1,141
|
|
-13.6%
|
|
293,243
|
|
-14.0%
|
|
|
Individual Equity Products
|
|
1,142
|
|
809
|
|
41.1%
|
|
|
|
23,986
|
|
18,617
|
|
28.8%
|
|
1,060
|
|
-13.6%
|
|
272,384
|
|
-14.0%
|
|
|
Futures
|
|
1,055
|
|
733
|
|
43.9%
|
|
|
|
22,165
|
|
16,867
|
|
31.4%
|
|
959
|
|
-14.2%
|
|
246,425
|
|
-14.5%
|
|
|
Options
|
|
87
|
|
76
|
|
13.9%
|
|
|
|
1,820
|
|
1,750
|
|
4.0%
|
|
101
|
|
-8.0%
|
|
25,959
|
|
-8.4%
|
|
|
Equity Index Products
|
|
98
|
|
93
|
|
5.3%
|
|
|
|
2,060
|
|
2,142
|
|
-3.8%
|
|
81
|
|
-13.8%
|
|
20,858
|
|
-14.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commodity Products
|
|
68
|
|
64
|
|
6.4%
|
|
|
|
1,422
|
|
1,464
|
|
-2.8%
|
|
81
|
|
24.8%
|
|
20,730
|
|
24.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Derivatives Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Options 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Euronext Options Contracts
|
|
3,936
|
|
3,360
|
|
17.1%
|
|
|
|
82,656
|
|
73,926
|
|
11.8%
|
|
4,406
|
|
20.0%
|
|
1,110,193
|
|
20.0%
|
|
|
Total Consolidated Options Contracts
|
|
14,224
|
|
14,567
|
|
-2.4%
|
|
|
|
298,702
|
|
320,466
|
|
-6.8%
|
|
16,764
|
|
17.0%
|
|
4,224,605
|
|
17.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Group Share of Total
|
|
27.7%
|
|
23.1%
|
|
|
|
|
|
27.7%
|
|
23.1%
|
|
|
|
26.3%
|
|
0.7%
|
|
26.3%
|
|
0.7%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Liffe U.S.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Futures and Futures Options Volume*
|
|
89.6
|
|
13.0
|
|
588.7%
|
|
|
|
1,882
|
|
286
|
|
557.4%
|
|
81.2
|
|
401.3%
|
|
20,937.6
|
|
413.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
European Cash Products (trades in thousands)
|
|
1,338
|
|
1,228
|
|
9.0%
|
|
|
|
28,095
|
|
28,235
|
|
-0.5%
|
|
1,711
|
|
17.1%
|
|
439,717
|
|
16.6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equities
|
|
1,287
|
|
1,177
|
|
9.3%
|
|
|
|
27,023
|
|
27,079
|
|
-0.2%
|
|
1,644
|
|
17.2%
|
|
422,517
|
|
16.8%
|
|
|
Exchange-Traded Funds
|
|
15
|
|
15
|
|
6.8%
|
|
|
|
325
|
|
334
|
|
-2.5%
|
|
21
|
|
16.5%
|
|
5,270
|
|
16.1%
|
|
|
Structured Products
|
|
31
|
|
30
|
|
1.6%
|
|
|
|
642
|
|
692
|
|
-7.2%
|
|
41
|
|
15.8%
|
|
10,649
|
|
15.4%
|
|
|
Bonds
|
|
5
|
|
6
|
|
-12.3%
|
|
|
|
104
|
|
130
|
|
-20.0%
|
|
5
|
|
-13.1%
|
|
1,281
|
|
-13.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Cash Products (shares in millions) 5
|
|
1,794
|
|
2,007
|
|
-10.6%
|
|
|
|
37,682
|
|
44,148
|
|
-14.6%
|
|
2,283
|
|
-12.1%
|
|
575,223
|
|
-12.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Listed (Tape A) Issues 4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
1,277
|
|
1,496
|
|
-14.6%
|
|
|
|
26,821
|
|
32,908
|
|
-18.5%
|
|
1,607
|
|
-14.7%
|
|
404,910
|
|
-14.7%
|
|
|
Matched Volume 6
|
|
1,212
|
|
1,419
|
|
-14.6%
|
|
|
|
25,445
|
|
31,224
|
|
-18.5%
|
|
1,523
|
|
-13.9%
|
|
383,863
|
|
-13.9%
|
|
|
Total NYSE Listed Consolidated Volume
|
|
3,623
|
|
4,050
|
|
-10.5%
|
|
|
|
76,086
|
|
89,092
|
|
-14.6%
|
|
4,370
|
|
-10.3%
|
|
1,101,268
|
|
-10.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
35.3%
|
|
36.9%
|
|
-1.6%
|
|
|
|
35.3%
|
|
36.9%
|
|
-1.6%
|
|
36.8%
|
|
-1.9%
|
|
36.8%
|
|
-1.9%
|
|
|
Matched Volume 6
|
|
33.4%
|
|
35.0%
|
|
-1.6%
|
|
|
|
33.4%
|
|
35.0%
|
|
-1.6%
|
|
34.9%
|
|
-1.5%
|
|
34.9%
|
|
-1.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Arca & Amex (Tape B) Listed Issues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
295
|
|
266
|
|
10.8%
|
|
|
|
6,192
|
|
5,855
|
|
5.8%
|
|
381
|
|
-1.1%
|
|
96,040
|
|
-1.1%
|
|
|
Matched Volume 6
|
|
263
|
|
240
|
|
9.6%
|
|
|
|
5,517
|
|
5,273
|
|
4.6%
|
|
343
|
|
-0.9%
|
|
86,460
|
|
-0.9%
|
|
|
Total NYSE Arca & Amex Listed Consolidated Volume
|
|
1,170
|
|
1,045
|
|
12.0%
|
|
|
|
24,580
|
|
22,998
|
|
6.9%
|
|
1,474
|
|
1.3%
|
|
371,409
|
|
1.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
25.2%
|
|
25.5%
|
|
-0.3%
|
|
|
|
25.2%
|
|
25.5%
|
|
-0.3%
|
|
25.9%
|
|
-0.6%
|
|
25.9%
|
|
-0.6%
|
|
|
Matched Volume 6
|
|
22.4%
|
|
22.9%
|
|
-0.5%
|
|
|
|
22.4%
|
|
22.9%
|
|
-0.5%
|
|
23.3%
|
|
-0.5%
|
|
23.3%
|
|
-0.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nasdaq Listed (Tape C) Issues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
222
|
|
245
|
|
-9.2%
|
|
|
|
4,669
|
|
5,386
|
|
-13.3%
|
|
295
|
|
-10.0%
|
|
74,274
|
|
-10.0%
|
|
|
Matched Volume 6
|
|
189
|
|
211
|
|
-10.1%
|
|
|
|
3,979
|
|
4,636
|
|
-14.2%
|
|
254
|
|
-8.3%
|
|
63,941
|
|
-8.3%
|
|
|
Total Nasdaq Listed Consolidated Volume
|
|
1,615
|
|
1,688
|
|
-4.3%
|
|
|
|
33,911
|
|
37,140
|
|
-8.7%
|
|
2,022
|
|
-7.8%
|
|
509,421
|
|
-7.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
13.8%
|
|
14.5%
|
|
-0.7%
|
|
|
|
13.8%
|
|
14.5%
|
|
-0.7%
|
|
14.6%
|
|
-0.4%
|
|
14.6%
|
|
-0.4%
|
|
|
Matched Volume 6
|
|
11.7%
|
|
12.5%
|
|
-0.8%
|
|
|
|
11.7%
|
|
12.5%
|
|
-0.8%
|
|
12.6%
|
|
0.0%
|
|
12.6%
|
|
0.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-Traded Funds 5,7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
279
|
|
237
|
|
17.7%
|
|
|
|
5,854
|
|
5,209
|
|
12.4%
|
|
360
|
|
-2.5%
|
|
90,741
|
|
-2.5%
|
|
|
Matched Volume 6
|
|
248
|
|
214
|
|
15.7%
|
|
|
|
5,202
|
|
4,710
|
|
10.4%
|
|
324
|
|
-2.6%
|
|
81,632
|
|
-2.6%
|
|
|
Total ETF Consolidated Volume
|
|
1,139
|
|
948
|
|
20.2%
|
|
|
|
23,917
|
|
20,852
|
|
14.7%
|
|
1,420
|
|
-0.4%
|
|
357,841
|
|
-0.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
24.5%
|
|
25.0%
|
|
-0.5%
|
|
|
|
24.5%
|
|
25.0%
|
|
-0.5%
|
|
25.4%
|
|
-0.5%
|
|
25.4%
|
|
-0.5%
|
|
|
Matched Volume 6
|
|
21.7%
|
|
22.6%
|
|
-0.9%
|
|
|
|
21.7%
|
|
22.6%
|
|
-0.9%
|
|
22.8%
|
|
-0.5%
|
|
22.8%
|
|
-0.5%
|
|
1 Data includes currency products.
2 Includes all trading activities for Bclear, NYSE Liffe's
clearing service for wholesale derivatives.
3 Includes trading in U.S. equity options contracts, not
equity-index options.
4 Includes all volume executed in NYSE Group crossing
sessions.
5 Represents the total number of shares of equity securities
and ETFs internally matched on the NYSE Group's exchanges or routed to
and executed at an external market center. NYSE Arca routing includes
odd-lots.
6 Represents the total number of shares of equity securities
and ETFs executed on the NYSE Group's exchanges.
7 Data included in previously identified categories.
* ADVs calculated with the appropriate number of NYSE Liffe
U.S. trading days.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated
Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading
which is double counted to include both buys and sells.
Source: NYSE Euronext
NYSE Euronext
Media:
+31.20.550.4488 (Amsterdam)
+32.2.509.1392
(Brussels)
+351.217.900.029 (Lisbon)
+44.20.7379.2789 (London)
+1.212.656.2411
(New York)
+33.1.49.27.11.33 (Paris)
or
Investor
Relations:
+1.212.656.5700 (New York)
+33.1.49.27.58.60 (Paris)